{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:08:35Z","timestamp":1790150915971,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T00:00:00Z","timestamp":1395878400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The genetic mutation resulting in osteogenesis imperfecta (OI) type V was recently characterised as a single point mutation (c.-14C &gt; T) in the 5\u2019 untranslated region (UTR) of <jats:italic>IFITM5<\/jats:italic>, a gene encoding a transmembrane protein with expression restricted to skeletal tissue. This mutation creates an alternative start codon and has been shown in a eukaryotic cell line to result in a longer variant of IFITM5, but its expression has not previously been demonstrated in bone from a patient with OI type V.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Sanger sequencing of the <jats:italic>IFITM5<\/jats:italic> 5\u2019 UTR was performed in our cohort of subjects with a clinical diagnosis of OI type V. Clinical data was collated from referring clinicians. RNA was extracted from a bone sample from one patient and Sanger sequenced to determine expression of wild-type and mutant <jats:italic>IFITM5<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>All nine subjects with OI type V were heterozygous for the c.-14C &gt; T <jats:italic>IFITM5<\/jats:italic> mutation. Clinically, there was heterogeneity in phenotype, particularly in the manifestation of bone fragility amongst subjects. Both wild-type and mutant <jats:italic>IFITM5<\/jats:italic> mRNA transcripts were present in bone.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The c.-14C &gt; T <jats:italic>IFITM5<\/jats:italic> mutation does not result in an RNA-null allele but is expressed in bone. Individuals with identical mutations in <jats:italic>IFITM5<\/jats:italic> have highly variable phenotypic expression, even within the same family.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2474-15-107","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T14:18:50Z","timestamp":1395929930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The IFITM5 mutation c.-14C &gt; T results in an elongated transcript expressed in human bone; and causes varying phenotypic severity of osteogenesis imperfecta type V"],"prefix":"10.1186","volume":"15","author":[{"given":"Syndia","family":"Lazarus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aideen M","family":"McInerney-Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona A","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Baynam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Broley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbra V","family":"Cavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig F","family":"Munns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes Egbertus Hans","family":"Pruijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sillence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulien A","family":"Terhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karena","family":"Pryce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Zankl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gethin","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,27]]},"reference":[{"issue":"Pathol Sect","key":"2062_CR1","first-page":"83","volume":"1","author":"WH Battle","year":"1908","unstructured":"Battle WH, Shattock SG: A remarkable case of diffuse cancellous osteoma of the femur, following a fracture, in which similar growths afterwards developed in connection with other bones. Proc R Soc Med. 1908, 1 (Pathol Sect): 83-115.","journal-title":"Proc R Soc Med"},{"key":"2062_CR2","volume-title":"The Brittle Bone Syndrome. Osteogenesis Imperfecta","author":"R Smith","year":"1983","unstructured":"Smith R, Francis MJO, Houghton GR: The Brittle Bone Syndrome. Osteogenesis Imperfecta. 1983, London: Butterworths"},{"issue":"1","key":"2062_CR3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1302\/0301-620X.57B1.2","volume":"57","author":"RJ Bauze","year":"1975","unstructured":"Bauze RJ, Smith R, Francis MJ: A new look at osteogenesis imperfecta. A clinical, radiological and biochemical study of forty-two patients. J Bone Joint Surg (Br). 1975, 57 (1): 2-12.","journal-title":"J Bone Joint Surg (Br)"},{"issue":"9","key":"2062_CR4","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1359\/jbmr.2000.15.9.1650","volume":"15","author":"FH Glorieux","year":"2000","unstructured":"Glorieux FH, Rauch F, Plotkin H, Ward L, Travers R, Roughley P, Lalic L, Glorieux DF, Fassier F, Bishop NJ: Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res. 2000, 15 (9): 1650-1658. 10.1359\/jbmr.2000.15.9.1650.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2062_CR5","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3346\/jkms.2006.21.4.709","volume":"21","author":"DY Lee","year":"2006","unstructured":"Lee DY, Cho TJ, Choi IH, Chung CY, Yoo WJ, Kim JH, Park YK: Clinical and radiological manifestations of osteogenesis imperfecta type V. J Korean Med Sci. 2006, 21 (4): 709-714. 10.3346\/jkms.2006.21.4.709.","journal-title":"J Korean Med Sci"},{"issue":"8","key":"2062_CR6","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1359\/jbmr.070418","volume":"22","author":"MS Cheung","year":"2007","unstructured":"Cheung MS, Glorieux FH, Rauch F: Natural history of hyperplastic callus formation in osteogenesis imperfecta type V. J Bone Miner Res. 2007, 22 (8): 1181-1186. 10.1359\/jbmr.070418.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2062_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1440-1754.2005.00567.x","volume":"41","author":"F Fleming","year":"2005","unstructured":"Fleming F, Woodhead HJ, Briody JN, Hall J, Cowell CT, Ault J, Kozlowski K, Sillence DO: Cyclic bisphosphonate therapy in osteogenesis imperfecta type V. J Paediatr Child Health. 2005, 41 (3): 147-151. 10.1111\/j.1440-1754.2005.00567.x.","journal-title":"J Paediatr Child Health"},{"issue":"1","key":"2062_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bone.2005.07.020","volume":"38","author":"L Zeitlin","year":"2006","unstructured":"Zeitlin L, Rauch F, Travers R, Munns C, Glorieux FH: The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta type V. Bone. 2006, 38 (1): 13-20. 10.1016\/j.bone.2005.07.020.","journal-title":"Bone"},{"issue":"2","key":"2062_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ajhg.2012.06.005","volume":"91","author":"TJ Cho","year":"2012","unstructured":"Cho TJ, Lee KE, Lee SK, Song SJ, Kim KJ, Jeon D, Lee G, Kim HN, Lee HR, Eom HH, Lee ZH, Kim OH, Park WY, Park SS, Ikegawa S, Yoo WJ, Choi IH, Kim JW: A single recurrent mutation in the 5\u2019-UTR of IFITM5 causes osteogenesis imperfecta type V. Am J Hum Genet. 2012, 91 (2): 343-348. 10.1016\/j.ajhg.2012.06.005.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"2062_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ajhg.2012.06.011","volume":"91","author":"O Semler","year":"2012","unstructured":"Semler O, Garbes L, Keupp K, Swan D, Zimmermann K, Becker J, Iden S, Wirth B, Eysel P, Koerber F, Schoenau E, Bohlander SK, Wollnik B, Netzer C: A mutation in the 5\u2019-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus. Am J Hum Genet. 2012, 91 (2): 349-357. 10.1016\/j.ajhg.2012.06.011.","journal-title":"Am J Hum Genet"},{"issue":"9","key":"2062_CR11","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1359\/jbmr.080412","volume":"23","author":"P Moffatt","year":"2008","unstructured":"Moffatt P, Gaumond MH, Salois P, Sellin K, Bessette MC, Godin E, de Oliveira PT, Atkins GJ, Nanci A, Thomas G: Bril: a novel bone-specific modulator of mineralization. J Bone Miner Res. 2008, 23 (9): 1497-1508. 10.1359\/jbmr.080412.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2062_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/jmedgenet-2012-101307","volume":"50","author":"F Rauch","year":"2013","unstructured":"Rauch F, Moffatt P, Cheung M, Roughley P, Lalic L, Lund AM, Ramirez N, Fahiminiya S, Majewski J, Glorieux FH: Osteogenesis imperfecta type V: marked phenotypic variability despite the presence of the IFITM5 c.-14C > T mutation in all patients. J Med Genet. 2013, 50 (1): 21-24. 10.1136\/jmedgenet-2012-101307.","journal-title":"J Med Genet"},{"issue":"7","key":"2062_CR13","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1002\/jbmr.1891","volume":"28","author":"JR Shapiro","year":"2013","unstructured":"Shapiro JR, Lietman C, Grover M, Lu JT, Nagamani SC, Dawson BC, Baldridge DM, Bainbridge MN, Cohn DH, Blazo M, Roberts TT, Brennen FS, Wu Y, Gibbs RA, Melvin P, Campeau PM, Lee BH: Phenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutation. J Bone Miner Res. 2013, 28 (7): 1523-1530. 10.1002\/jbmr.1891.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2062_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/MCD.0b013e32836032f0","volume":"22","author":"M Balasubramanian","year":"2013","unstructured":"Balasubramanian M, Parker MJ, Dalton A, Giunta C, Lindert U, Peres LC, Wagner BE, Arundel P, Offiah A, Bishop NJ: Genotype-phenotype study in type V osteogenesis imperfecta. Clin Dysmorphol. 2013, 22 (3): 93-101. 10.1097\/MCD.0b013e32836032f0.","journal-title":"Clin Dysmorphol"},{"issue":"8","key":"2062_CR15","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1002\/ajmg.a.36025","volume":"161A","author":"M Takagi","year":"2013","unstructured":"Takagi M, Sato S, Hara K, Tani C, Miyazaki O, Nishimura G, Hasegawa T: A recurrent mutation in the 5\u2019-UTR of IFITM5 causes osteogenesis imperfecta type V. Am J Med Genet A. 2013, 161A (8): 1980-1982.","journal-title":"Am J Med Genet A"},{"issue":"5","key":"2062_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/ng1783","volume":"38","author":"EM Shore","year":"2006","unstructured":"Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH, Connor JM, Delai P, Glaser DL, LeMerrer M, Morhart R, Rogers JG, Smith R, Triffitt JT, Urtizberea JA, Zasloff M, Brown MA, Kaplan FS: A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006, 38 (5): 525-527. 10.1038\/ng1783.","journal-title":"Nat Genet"},{"issue":"11","key":"2062_CR17","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1002\/jbmr.1983","volume":"28","author":"M Grover","year":"2013","unstructured":"Grover M, Campeau PM, Lietman CD, Lu JT, Gibbs RA, Schlesinger AE, Lee BH: Osteogenesis imperfecta without features of type V caused by a mutation in the IFITM5 gene. J Bone Miner Res. 2013, 28 (11): 2333-2337. 10.1002\/jbmr.1983.","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2062_CR18","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.2106\/JBJS.F.01287","volume":"89","author":"AM Fassier","year":"2007","unstructured":"Fassier AM, Rauch F, Aarabi M, Janelle C, Fassier F: Radial head dislocation and subluxation in osteogenesis imperfecta. J Bone Joint Surg Am. 2007, 89 (12): 2694-2704. 10.2106\/JBJS.F.01287.","journal-title":"J Bone Joint Surg Am"},{"issue":"5","key":"2062_CR19","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/ajmg.a.33909","volume":"155A","author":"ML Warman","year":"2011","unstructured":"Warman ML, Cormier-Daire V, Hall C, Krakow D, Lachman R, LeMerrer M, Mortier G, Mundlos S, Nishimura G, Rimoin DL, Robertson S, Savarirayan R, Sillence D, Spranger J, Unger S, Zabel B, Superti-Furga A: Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet A. 2011, 155A (5): 943-968.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"2062_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/jmg.16.2.101","volume":"16","author":"DO Sillence","year":"1979","unstructured":"Sillence DO, Senn A, Danks DM: Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979, 16 (2): 101-116. 10.1136\/jmg.16.2.101.","journal-title":"J Med Genet"},{"issue":"1","key":"2062_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmg.2009.10.007","volume":"53","author":"FS Van Dijk","year":"2010","unstructured":"Van Dijk FS, Pals G, Van Rijn RR, Nikkels PG, Cobben JM: Classification of osteogenesis imperfecta revisited. Eur J Med Genet. 2010, 53 (1): 1-5. 10.1016\/j.ejmg.2009.10.007.","journal-title":"Eur J Med Genet"},{"issue":"9","key":"2062_CR22","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrendo.2011.81","volume":"7","author":"A Forlino","year":"2011","unstructured":"Forlino A, Cabral WA, Barnes AM, Marini JC: New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol. 2011, 7 (9): 540-557. 10.1038\/nrendo.2011.81.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2062_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1359\/jbmr.090720","volume":"25","author":"E Daley","year":"2010","unstructured":"Daley E, Streeten EA, Sorkin JD, Kuznetsova N, Shapses SA, Carleton SM, Shuldiner AR, Marini JC, Phillips CL, Goldstein SA, Leikin S, McBride DJ: Variable bone fragility associated with an Amish COL1A2 variant and a knock-in mouse model. J Bone Miner Res. 2010, 25 (2): 247-261. 10.1359\/jbmr.090720.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2062_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00774-010-0221-0","volume":"29","author":"N Hanagata","year":"2011","unstructured":"Hanagata N, Li X, Morita H, Takemura T, Li J, Minowa T: Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice. J Bone Miner Metab. 2011, 29 (3): 279-290. 10.1007\/s00774-010-0221-0.","journal-title":"J Bone Miner Metab"},{"issue":"5","key":"2062_CR25","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.bone.2012.07.024","volume":"51","author":"Y Liu","year":"2012","unstructured":"Liu Y, Liu H, Titus L, Boden SD: Natural antisense transcripts enhance bone formation by increasing sense IFITM5 transcription. Bone. 2012, 51 (5): 933-938. 10.1016\/j.bone.2012.07.024.","journal-title":"Bone"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-15-107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2474-15-107\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-15-107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-15-107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:18:52Z","timestamp":1630552732000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/1471-2474-15-107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,27]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2062"],"URL":"https:\/\/doi.org\/10.1186\/1471-2474-15-107","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,27]]},"assertion":[{"value":"12 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"107"}}